Tony Zhang

Professor Tony Zhang is Deputy Dean (International) in the School of Health and Biomedical Sciences, RMIT University, Melbourne Australia with 15 years academic leadership including 5 years as Associate Dean and 10 years as Discipline Leader in a School/Faculty with more than 6,000 students in 11 disciplines and >200 faculty academic staff. He also has 10 years experience as deputy director of a WHO Collaboration Centre and, >10 years as co-deputy director of an International Research Centre.

Tony’s evidence-based clinical research expertise focuses on methodologies including randomised controlled clinical trials, epidemiological studies, systematic review/meta-analysis, population survey, implementation sciences, and qualitative research. Tony has published >30 evidence-based clinical monographs/book chapters, and >200 peer-reviewed journal articles including The Lancet, JAMA Oncology, Thorax, Cochrane Database of Systematic Reviews; British Journal of Dermatology; and Journal of the American Academy of Dermatology (>30,000 citations) with government and industry funding support.

Tony has been an Expert Advisor/Assessor/Reviewer for government bodies including the Australian Tertiary Education Quality and Standards Agency (TEQSA); National Health & Medical Research Council (NHMRC); Australian Research Council (ARC); Australian Office for Learning and Teaching Grants (OLTC); New Zealand Health Research Council (HRC); & Hong Kong Health and Medical Research Fund (HMRF). He is also serving as an Editorial Board Member for 7 peer-reviewed journals including the American Journal of Chinese Medicine & BMC Complementary Medicine and Therapies.

Tony has supervised 30 PhD students to completion and he currently supervise 8 PhD students.

Tony is in the list of the World’s Top 2% Scientist 2023 & 2024 & 2025 by Stanford University (in both categories of “career-long” and “single recent”) – based on standardized citations, h-index, co-authorship adjusted hm-index and c-score.